Overview
Nevoid melanoma brain metastases represent a challenging clinical scenario requiring multidisciplinary management, often involving radiation therapy to control local disease and systemic treatments to improve survival. 12Diagnosis
Imaging: MRI or CT scans for detection and staging of brain metastases.
Histopathological confirmation: Biopsy to confirm melanoma origin.
Grading: Not explicitly detailed in provided abstracts; typically based on size, number of metastases, and extracranial disease status.Management
First-line treatments:
- Radiation Therapy:
- Whole Brain Radiation Therapy (WBRT): Median survival post-diagnosis of brain metastasis ~3.5 months.
- Stereotactic Radiosurgery (SRS): Median survival post-diagnosis of brain metastasis ~7.5 months. 1
- Immunotherapy: Often used in conjunction with radiation therapy to enhance survival outcomes. 2
Adjunctive treatments:
- Combination of Stereotactic Radiotherapy (SRT) with immunotherapy shows potential survival benefits but requires individualized assessment due to low-quality evidence. 2Special Populations
No specific details provided regarding management in pregnancy, pediatrics, elderly, or patients with comorbidities based on the given abstracts.Key Recommendations
Consider stereotactic radiosurgery (SRS) over whole brain radiation therapy (WBRT) for improved survival in patients with melanoma brain metastases due to longer median survival times observed. (Evidence: Moderate 1)
Evaluate the combination of stereotactic radiotherapy (SRT) with immunotherapy on an individual basis, considering potential survival advantages and low rates of ≥G3 late toxicity, acknowledging the very low quality of evidence supporting this approach. (Evidence: Weak 2)
Multidisciplinary team discussion is essential for treatment planning in melanoma brain metastases, especially when considering combination therapies like SRT plus immunotherapy. (Evidence: Expert opinion)References
1 Thompson JF, Williams GJ, Hong AM. Radiation therapy for melanoma brain metastases: a systematic review. Radiology and oncology 2022. link
2 Lancellotta V, Del Regno L, Di Stefani A, Fionda B, Marazzi F, Rossi E et al.. The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review. La Radiologia medica 2022. link